Back to Search
MARCOS DE LIMA, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1851491195IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
35-120066(OH)
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
K4674(TX)
Education
OTHER
Class of 1986
Research & Publications (20)
Effect of photodynamic therapy on the healing of cutaneous third-degree-burn: histological study in rats.
PMID 19533211·Lasers Med Sci·2010
4-observational
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.
PMID 19668237·Bone Marrow Transplant·2010
3-trial
Chitosan membranes modified by contact with poly(acrylic acid).
PMID 19555925·Carbohydr Res·2009
8-other
Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia.
PMID 19561406·Curr Opin Oncol·2009
4-observational
Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes.
PMID 19361753·Biol Blood Marrow Transplant·2009
2-rct
GP3 is a structural component of the PRRSV type II (US) virion.
PMID 19467555·Virology·2009
7-preclinical
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
PMID 19450756·Biol Blood Marrow Transplant·2009
8-other
Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation.
PMID 19660722·Biol Blood Marrow Transplant·2009
8-other
The surgical management of the sentinel lymph node in cutaneous melanoma might be different when the primary lesion was previously resected with 1 cm margin.
PMID 19424099·Nucl Med Commun·2009
3-trial
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma.
PMID 19384931·Am J Hematol·2009
8-other
Structure and activity analysis of two spider toxins that alter sodium channel inactivation kinetics.
PMID 19231838·Biochemistry·2009
8-other
Endoscopic treatment of Roux-en-Y gastric bypass-related gastrocutaneous fistulas using a novel biomaterial.
PMID 19296165·Surg Endosc·2009
3-trial
Polyethylenimine of various molecular weights as adjuvant for transfection mediated by cationic liposomes.
PMID 19280381·Mol Membr Biol·2009
8-other
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia.
PMID 19235255·Cancer·2009
8-other
Population-based multicentric survey of hepatitis B infection and risk factor differences among three regions in Brazil.
PMID 19635877·Am J Trop Med Hyg·2009
8-other
MDM2, P53, P21WAF1 and pAKT protein levels in genesis and behaviour of adenoid cystic carcinoma.
PMID 19679062·Cancer Epidemiol·2009
4-observational
Preclinical pharmacokinetic and pharmacodynamic evaluation of thiazolidinone PG15: an anti-inflammatory candidate.
PMID 19222906·J Pharm Pharmacol·2009
4-observational
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
PMID 19167676·Biol Blood Marrow Transplant·2009
6-review
Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome.
PMID 19151791·Bone Marrow Transplant·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11100 EUCLID AVE
CLEVELAND, OH 44106 - Phone
- (216) 844-3951
Quick Facts
- NPI
- 1851491195
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile